Antifungal Prophylaxis Utilization and the Associated Clinical Outcomes Among Pediatric Patients with Hematological Malignancies or Undergoing Hematopoietic Stem Cell Transplantation. [PDF]
Al Siyabi B +4 more
europepmc +1 more source
Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection. [PDF]
Ross JA +13 more
europepmc +1 more source
Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective Cohort. [PDF]
Melica G +17 more
europepmc +1 more source
Impact of Inflammatory Burden on Voriconazole Exposure in Oncohematological Pediatric Patients Receiving Antifungal Prophylaxis after Allogeneic HCT. [PDF]
Gatti M +7 more
europepmc +1 more source
Improved survival after acute graft-versus-host disease diagnosis in the modern era [PDF]
et al.,, Hayashi, Robert J, Vig, Ravi
core +1 more source
Risk Factors for Invasive Fungal Infection in Lung Transplant Recipients on Universal Antifungal Prophylaxis. [PDF]
Huggins JP +7 more
europepmc +1 more source
Antifungal Prophylaxis in the Treatment Combination of Hypomethylating Agents and Venetoclax for AML: A Survey Study of the Turkish Society of Hematology Subcommittee on Infections and Supportive Therapies in Hematology [PDF]
Alp Kırkızlar T, Özkocaman V.
europepmc +1 more source
Oral nystatin as antifungal prophylaxis in critically ill patients: an old SDD tool to be renewed? [PDF]
Eggimann, Philippe +2 more
core

